Review: Fibrodysplasia Ossificans Progressiva
Journal: International Research Journal of Pharmacy and Medical Sciences (IRJPMS) (Vol.7, No. 6)Publication Date: 2024-11-11
Authors : Vankodoth Sireesha Faiqua Fatima Shafeen Sultana Shiva Sai Kumar;
Page : 1-2
Keywords : ACVR1 Gene Mutation; Bone Morphogenetic Protein (BMP) Signaling; Endochondral Ossification; Fibrodysplasia Ossificans Progressiva; Future Therapies in FOP; Genetic Disorder; Heterotopic Ossification;
Abstract
—Fibrodysplasia Ossificans Progressiva (FOP) is an ultra-rare genetic disorder characterized by heterotopic ossification of connective tissues and progressive loss of mobility. FOP is caused by mutations in the ACVR1 gene, leading to abnormal bone formation in muscles, tendons, and ligaments. This review explores the clinical features, genetic basis, pathophysiology, current management, and future directions for research and therapy
Other Latest Articles
- Touristmemorfosis as a Model for Tourism Development in the Tulamben – Amed Tourist Area
- Improving Engineers’ Utilization and Performance in Electricity Company
- The Participation of Women in Grassroots Democracy in India
- Effective Strategies to Protect Web Applications from CSRF Attacks
- The Role of BIM Technologies in Capital Construction Project Management
Last modified: 2024-11-17 20:10:58